These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 7110993)
1. [Acute hemolysis caused by glucose-6-phosphate dehydrogenase deficiency at the outset of myeloma therapy. Role of melphalan?]. Casassus P; Vannetzel JM; Lortholary P Nouv Presse Med; 1982 Jun; 11(30):2296. PubMed ID: 7110993 [No Abstract] [Full Text] [Related]
2. [Myeloma, melphalan and acute myelo-monocytic leukemia. Apropos of a case]. Cywiner-Golenzer C; Adotti F; Marsan C; Quillard A; Henon P; Grimaldi A; Dryll A Sem Hop; 1974 Jan; 50(3):207-11. PubMed ID: 4367926 [No Abstract] [Full Text] [Related]
3. Acute hemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes. Kaplan M; Hammerman C; Vreman HJ; Stevenson DK; Beutler E J Pediatr; 2001 Jul; 139(1):137-40. PubMed ID: 11445808 [TBL] [Abstract][Full Text] [Related]
4. [Changes in peripheral blood monocyte number in patients with multiple myeloma treated with melphalan]. Mendek-Czajkowska E; Rostkowska J; Mariańska B; Sawicki Z; Maj S Acta Haematol Pol; 1984; 15(3-4):119-24. PubMed ID: 6537120 [No Abstract] [Full Text] [Related]
5. [Drugs and other agents leading to increased hemolysis in persons with glucose-6-phosphate dehydrogenase deficiency]. Roos D; Verweij SL Ned Tijdschr Geneeskd; 1984 Feb; 128(6):244-5. PubMed ID: 6709092 [No Abstract] [Full Text] [Related]
6. [Myeloma with hypereosinophilia. Eosinophil reaction following melphalan]. Ozgüven O; Sebik F; Basci A Presse Med; 1983 Mar; 12(11):704. PubMed ID: 6220307 [No Abstract] [Full Text] [Related]
7. [Case of laparoscopic cholecystectomy in a patient with glucose-6-dehydrogenase deficiency]. Wada R; Hino H; Ando Y; Tateda T Masui; 2008 Feb; 57(2):200-2. PubMed ID: 18277571 [TBL] [Abstract][Full Text] [Related]
8. Drug-induced haemolysis and methaemoglobinaemia in glucose 6-phosphate dehydrogenase deficiency. Dalal BI; Kollmannsberger C Br J Haematol; 2005 May; 129(3):291. PubMed ID: 15842651 [No Abstract] [Full Text] [Related]
9. Interleukin-6 affects melphalan-induced DNA damage and repair in human multiple myeloma cells. Efferth T; Fabry U; Osieka R Anticancer Res; 2002; 22(1A):231-4. PubMed ID: 12017294 [TBL] [Abstract][Full Text] [Related]
10. Donor blood glucose 6-phosphate dehydrogenase deficiency reduces the efficacy of exchange transfusion in neonatal hyperbilirubinemia. Samanta S; Kumar P; Kishore SS; Garewal G; Narang A Pediatrics; 2009 Jan; 123(1):e96-e100. PubMed ID: 19103674 [TBL] [Abstract][Full Text] [Related]
11. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479. Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of G6PD deficiency. Frank JE Am Fam Physician; 2005 Oct; 72(7):1277-82. PubMed ID: 16225031 [TBL] [Abstract][Full Text] [Related]